Syfovre Injections Side Effects: Controversy Emerge

What is Syfovre?

When did the FDA approve Syfovre?

What’s the controversy about?

How does Apellis respond to the controversy?

Is there any Syfovre lawsuits against Apellis?

[{"selector":"#anim-bcc24823-a7cb-45cb-bae4-e3cc04b0bb5b","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bdcd0143-5730-4421-968c-1605c20dcb97","keyframes":{"transform":["translate3d(-106.8306%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Syfovre Injections Side Effects: Controversy Emerge

What is Syfovre?

Syfovre is a C3 inhibitor injection to treat geographic atrophy (GA). GA is an advanced form of late stage dry age-related macular degeneration.

When did the FDA approve Syfovre?

Apellis Pharmaceuticals got approval for Syfovre in February 2023. It is prescribed to slow down the GA lesion growth.

What’s the controversy about?

Syfovre is proved to cause side effects like ocular discomfort, vitreous floaters, retinal hemorrhage, intraocular inflammation in the eye.

How does Apellis respond to the controversy?

Apellis claimed- There was zero vasculitis reported in clinical trials. Only 0.01% events were reported.

Is there any Syfovre lawsuits against Apellis?

Apart from the investor lawsuits, no victims have come forward with one so far.